PlaqueTec
Pre-clinicalPlaqueTec is pioneering the development of biomarker-based, cardiovascular personalised medicine strategies, using its novel Liquid Biopsy System, to transform the prevention, diagnosis and treatment of Coronary Artery Disease - the leading cause of death worldwide.
Founded
2014
Focus
Diagnostics
About
PlaqueTec is pioneering the development of biomarker-based, cardiovascular personalised medicine strategies, using its novel Liquid Biopsy System, to transform the prevention, diagnosis and treatment of Coronary Artery Disease - the leading cause of death worldwide.
Funding History
2Total raised: $10M
Series A$8MCambridge Innovation CapitalSep 15, 2020
Seed$2MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2014
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile